Showing results (461-470 of 482) with videos related to

Sort By:
Pageof 49
Science (New York, N.Y.)|June 1, 1979
Extreme ultraviolet observations from voyager 1 encounter with jupiterA L Broadfoot, M J Belton, P Z Takacs, et al.
Cancer Research|September 5, 2006
Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinomaLiz Y Han, Charles N Landen, Jose G Trevino, et al.
Blood Advances|November 8, 2019
Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cellsTomasz Sewastianik, Maria Luisa Guerrera, Keith Adler, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Bone-targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analoguesRaji Sundaramoorthi, William C Shakespeare, Terence P Keenan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 3, 2025
Chiral Lemniscate Formation in Magnetic Field Controlled Topological Fluid FlowsMatt Jellicoe, Zoe Gardner, Amjad E H Alotaibi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2000
Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activityW Shakespeare, M Yang, R Bohacek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical ModelsSen Zhang, Rana Anjum, Rachel Squillace, et al.
Journal of Medicinal Chemistry|January 11, 2013
Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitorsAnna Kohlmann, Stephan G Zech, Feng Li, et al.
BMJ (Clinical Research Ed.)|February 14, 2023
Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes: cluster randomised controlled trialRichard Holland, Christine Bond, David P Alldred, et al.
Pageof 49